PMC:7341464 / 4130-5693 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T26","span":{"begin":88,"end":96},"obj":"SP_7"},{"id":"T27","span":{"begin":333,"end":337},"obj":"UBERON:0001456"},{"id":"T28","span":{"begin":734,"end":743},"obj":"SP_7"},{"id":"T29","span":{"begin":785,"end":791},"obj":"UBERON:0000473"},{"id":"T30","span":{"begin":963,"end":968},"obj":"UBERON:0007023"},{"id":"T31","span":{"begin":1270,"end":1278},"obj":"SP_7"},{"id":"T20974","span":{"begin":88,"end":96},"obj":"SP_7"},{"id":"T88967","span":{"begin":333,"end":337},"obj":"UBERON:0001456"},{"id":"T28626","span":{"begin":734,"end":743},"obj":"SP_7"},{"id":"T93531","span":{"begin":785,"end":791},"obj":"UBERON:0000473"},{"id":"T59311","span":{"begin":963,"end":968},"obj":"UBERON:0007023"},{"id":"T51667","span":{"begin":1270,"end":1278},"obj":"SP_7"}],"text":"Table 2 Information on preventive measures, symptoms and hospital admissions related to COVID-19 in CML patients at inclusion.\nPatients (N = 148) Housemates (N = 124)\n% (n) % (n)\nVisited affected areaa 3.4 (5) 4.1 (5)\nPreventive measuresb\n None 0 N/A\n Avoid shaking hands 85.1 (126) N/A\n Clean hands often 84.5 (125) N/A\n Use of face mask 2.7 (4) N/A\n Working from home, just as same-function colleagues 31.8 (47) N/A\n Working from home, in contrary to same-function colleagues 6.8 (10) N/A\n Self-isolation 41.2 (61) N/A\n Other 14.9 (22) N/A\nSymptomsb\n Rhinitis 16.9 (25) 8.9 (11)\n Coughing 14.2 (21) 6.5 (8)\n Sore throat 4.1 (6) 2.4 (3)\n Dyspnoea 10.8 (16) 2.4 (3)\n Fever 0 (0) 0 (0)\n No symptoms 69.6 (103) 84.6 (104)\nSARS-CoV2 testing\n Tested, positive 0.7 (1) 0.0\n Tested, negative 0.7 (1) 0.0\n Not tested 98.0 (145) 100 (123)\n Unknown 0.7 (1) 0\nHospital admissionc 0.7 (1) 0.0 (0)\n Intensive Care Unit admission 0.0 (0) 0.0 (0)\nLives with adult housemate 85.9 (128) –\nN = 131 N = 106\n% (n) % (n)\nVaccines\n Annual influenza vaccination\n Yes 58.0 (76) 35.8 (38)\n No 42.0 (55) 64.1 (68)\n If available, would take corona vaccine\n Yes 76.3 (100) 68.9 (73)\n No 3.8 (5) 0.9 (1)\n Do not know 19.8 (26) 30.2 (32)\naAffected areas with high risk of COVID-19 as established by National Institute for Public Health and the Environment: Italy, Austria, Nordrhein Westfalen (Germany), Madrid (Spain), China, South Korea, Iran.\nbMultiple answers possible.\ncHospital/ICU admission because of the following symptoms: coughing, dyspnoea and/or fever."}

LitCovid-PD-FMA-UBERON

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":333,"end":337},"obj":"Body_part"},{"id":"T2","span":{"begin":626,"end":632},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma24728"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma228738"}],"text":"Table 2 Information on preventive measures, symptoms and hospital admissions related to COVID-19 in CML patients at inclusion.\nPatients (N = 148) Housemates (N = 124)\n% (n) % (n)\nVisited affected areaa 3.4 (5) 4.1 (5)\nPreventive measuresb\n None 0 N/A\n Avoid shaking hands 85.1 (126) N/A\n Clean hands often 84.5 (125) N/A\n Use of face mask 2.7 (4) N/A\n Working from home, just as same-function colleagues 31.8 (47) N/A\n Working from home, in contrary to same-function colleagues 6.8 (10) N/A\n Self-isolation 41.2 (61) N/A\n Other 14.9 (22) N/A\nSymptomsb\n Rhinitis 16.9 (25) 8.9 (11)\n Coughing 14.2 (21) 6.5 (8)\n Sore throat 4.1 (6) 2.4 (3)\n Dyspnoea 10.8 (16) 2.4 (3)\n Fever 0 (0) 0 (0)\n No symptoms 69.6 (103) 84.6 (104)\nSARS-CoV2 testing\n Tested, positive 0.7 (1) 0.0\n Tested, negative 0.7 (1) 0.0\n Not tested 98.0 (145) 100 (123)\n Unknown 0.7 (1) 0\nHospital admissionc 0.7 (1) 0.0 (0)\n Intensive Care Unit admission 0.0 (0) 0.0 (0)\nLives with adult housemate 85.9 (128) –\nN = 131 N = 106\n% (n) % (n)\nVaccines\n Annual influenza vaccination\n Yes 58.0 (76) 35.8 (38)\n No 42.0 (55) 64.1 (68)\n If available, would take corona vaccine\n Yes 76.3 (100) 68.9 (73)\n No 3.8 (5) 0.9 (1)\n Do not know 19.8 (26) 30.2 (32)\naAffected areas with high risk of COVID-19 as established by National Institute for Public Health and the Environment: Italy, Austria, Nordrhein Westfalen (Germany), Madrid (Spain), China, South Korea, Iran.\nbMultiple answers possible.\ncHospital/ICU admission because of the following symptoms: coughing, dyspnoea and/or fever."}

LitCovid-PD-UBERON

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T3","span":{"begin":268,"end":273},"obj":"Body_part"},{"id":"T4","span":{"begin":297,"end":302},"obj":"Body_part"},{"id":"T5","span":{"begin":333,"end":337},"obj":"Body_part"},{"id":"T6","span":{"begin":626,"end":632},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0002398"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0002398"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0001456"},{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"}],"text":"Table 2 Information on preventive measures, symptoms and hospital admissions related to COVID-19 in CML patients at inclusion.\nPatients (N = 148) Housemates (N = 124)\n% (n) % (n)\nVisited affected areaa 3.4 (5) 4.1 (5)\nPreventive measuresb\n None 0 N/A\n Avoid shaking hands 85.1 (126) N/A\n Clean hands often 84.5 (125) N/A\n Use of face mask 2.7 (4) N/A\n Working from home, just as same-function colleagues 31.8 (47) N/A\n Working from home, in contrary to same-function colleagues 6.8 (10) N/A\n Self-isolation 41.2 (61) N/A\n Other 14.9 (22) N/A\nSymptomsb\n Rhinitis 16.9 (25) 8.9 (11)\n Coughing 14.2 (21) 6.5 (8)\n Sore throat 4.1 (6) 2.4 (3)\n Dyspnoea 10.8 (16) 2.4 (3)\n Fever 0 (0) 0 (0)\n No symptoms 69.6 (103) 84.6 (104)\nSARS-CoV2 testing\n Tested, positive 0.7 (1) 0.0\n Tested, negative 0.7 (1) 0.0\n Not tested 98.0 (145) 100 (123)\n Unknown 0.7 (1) 0\nHospital admissionc 0.7 (1) 0.0 (0)\n Intensive Care Unit admission 0.0 (0) 0.0 (0)\nLives with adult housemate 85.9 (128) –\nN = 131 N = 106\n% (n) % (n)\nVaccines\n Annual influenza vaccination\n Yes 58.0 (76) 35.8 (38)\n No 42.0 (55) 64.1 (68)\n If available, would take corona vaccine\n Yes 76.3 (100) 68.9 (73)\n No 3.8 (5) 0.9 (1)\n Do not know 19.8 (26) 30.2 (32)\naAffected areas with high risk of COVID-19 as established by National Institute for Public Health and the Environment: Italy, Austria, Nordrhein Westfalen (Germany), Madrid (Spain), China, South Korea, Iran.\nbMultiple answers possible.\ncHospital/ICU admission because of the following symptoms: coughing, dyspnoea and/or fever."}

LitCovid-PD-MONDO

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T48","span":{"begin":88,"end":96},"obj":"Disease"},{"id":"T49","span":{"begin":100,"end":103},"obj":"Disease"},{"id":"T51","span":{"begin":562,"end":570},"obj":"Disease"},{"id":"T52","span":{"begin":621,"end":632},"obj":"Disease"},{"id":"T53","span":{"begin":734,"end":738},"obj":"Disease"},{"id":"T54","span":{"begin":1037,"end":1046},"obj":"Disease"},{"id":"T55","span":{"begin":1270,"end":1278},"obj":"Disease"}],"attributes":[{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A49","pred":"mondo_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/MONDO_0001014"},{"id":"A50","pred":"mondo_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/MONDO_0011996"},{"id":"A51","pred":"mondo_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/MONDO_0003014"},{"id":"A52","pred":"mondo_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/MONDO_0002258"},{"id":"A53","pred":"mondo_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A54","pred":"mondo_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A55","pred":"mondo_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Table 2 Information on preventive measures, symptoms and hospital admissions related to COVID-19 in CML patients at inclusion.\nPatients (N = 148) Housemates (N = 124)\n% (n) % (n)\nVisited affected areaa 3.4 (5) 4.1 (5)\nPreventive measuresb\n None 0 N/A\n Avoid shaking hands 85.1 (126) N/A\n Clean hands often 84.5 (125) N/A\n Use of face mask 2.7 (4) N/A\n Working from home, just as same-function colleagues 31.8 (47) N/A\n Working from home, in contrary to same-function colleagues 6.8 (10) N/A\n Self-isolation 41.2 (61) N/A\n Other 14.9 (22) N/A\nSymptomsb\n Rhinitis 16.9 (25) 8.9 (11)\n Coughing 14.2 (21) 6.5 (8)\n Sore throat 4.1 (6) 2.4 (3)\n Dyspnoea 10.8 (16) 2.4 (3)\n Fever 0 (0) 0 (0)\n No symptoms 69.6 (103) 84.6 (104)\nSARS-CoV2 testing\n Tested, positive 0.7 (1) 0.0\n Tested, negative 0.7 (1) 0.0\n Not tested 98.0 (145) 100 (123)\n Unknown 0.7 (1) 0\nHospital admissionc 0.7 (1) 0.0 (0)\n Intensive Care Unit admission 0.0 (0) 0.0 (0)\nLives with adult housemate 85.9 (128) –\nN = 131 N = 106\n% (n) % (n)\nVaccines\n Annual influenza vaccination\n Yes 58.0 (76) 35.8 (38)\n No 42.0 (55) 64.1 (68)\n If available, would take corona vaccine\n Yes 76.3 (100) 68.9 (73)\n No 3.8 (5) 0.9 (1)\n Do not know 19.8 (26) 30.2 (32)\naAffected areas with high risk of COVID-19 as established by National Institute for Public Health and the Environment: Italy, Austria, Nordrhein Westfalen (Germany), Madrid (Spain), China, South Korea, Iran.\nbMultiple answers possible.\ncHospital/ICU admission because of the following symptoms: coughing, dyspnoea and/or fever."}

LitCovid-PD-CLO

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T33","span":{"begin":141,"end":144},"obj":"http://purl.obolibrary.org/obo/CLO_0001079"},{"id":"T34","span":{"begin":250,"end":251},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T35","span":{"begin":287,"end":288},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T36","span":{"begin":322,"end":323},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T37","span":{"begin":333,"end":337},"obj":"http://purl.obolibrary.org/obo/UBERON_0001456"},{"id":"T38","span":{"begin":353,"end":354},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T39","span":{"begin":421,"end":422},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T40","span":{"begin":495,"end":496},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T41","span":{"begin":526,"end":527},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T42","span":{"begin":542,"end":544},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T43","span":{"begin":548,"end":549},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T44","span":{"begin":586,"end":588},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T45","span":{"begin":744,"end":751},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T46","span":{"begin":754,"end":760},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T47","span":{"begin":785,"end":791},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T48","span":{"begin":820,"end":826},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Table 2 Information on preventive measures, symptoms and hospital admissions related to COVID-19 in CML patients at inclusion.\nPatients (N = 148) Housemates (N = 124)\n% (n) % (n)\nVisited affected areaa 3.4 (5) 4.1 (5)\nPreventive measuresb\n None 0 N/A\n Avoid shaking hands 85.1 (126) N/A\n Clean hands often 84.5 (125) N/A\n Use of face mask 2.7 (4) N/A\n Working from home, just as same-function colleagues 31.8 (47) N/A\n Working from home, in contrary to same-function colleagues 6.8 (10) N/A\n Self-isolation 41.2 (61) N/A\n Other 14.9 (22) N/A\nSymptomsb\n Rhinitis 16.9 (25) 8.9 (11)\n Coughing 14.2 (21) 6.5 (8)\n Sore throat 4.1 (6) 2.4 (3)\n Dyspnoea 10.8 (16) 2.4 (3)\n Fever 0 (0) 0 (0)\n No symptoms 69.6 (103) 84.6 (104)\nSARS-CoV2 testing\n Tested, positive 0.7 (1) 0.0\n Tested, negative 0.7 (1) 0.0\n Not tested 98.0 (145) 100 (123)\n Unknown 0.7 (1) 0\nHospital admissionc 0.7 (1) 0.0 (0)\n Intensive Care Unit admission 0.0 (0) 0.0 (0)\nLives with adult housemate 85.9 (128) –\nN = 131 N = 106\n% (n) % (n)\nVaccines\n Annual influenza vaccination\n Yes 58.0 (76) 35.8 (38)\n No 42.0 (55) 64.1 (68)\n If available, would take corona vaccine\n Yes 76.3 (100) 68.9 (73)\n No 3.8 (5) 0.9 (1)\n Do not know 19.8 (26) 30.2 (32)\naAffected areas with high risk of COVID-19 as established by National Institute for Public Health and the Environment: Italy, Austria, Nordrhein Westfalen (Germany), Madrid (Spain), China, South Korea, Iran.\nbMultiple answers possible.\ncHospital/ICU admission because of the following symptoms: coughing, dyspnoea and/or fever."}

LitCovid-PD-CHEBI

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":1136,"end":1142},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_37409"}],"text":"Table 2 Information on preventive measures, symptoms and hospital admissions related to COVID-19 in CML patients at inclusion.\nPatients (N = 148) Housemates (N = 124)\n% (n) % (n)\nVisited affected areaa 3.4 (5) 4.1 (5)\nPreventive measuresb\n None 0 N/A\n Avoid shaking hands 85.1 (126) N/A\n Clean hands often 84.5 (125) N/A\n Use of face mask 2.7 (4) N/A\n Working from home, just as same-function colleagues 31.8 (47) N/A\n Working from home, in contrary to same-function colleagues 6.8 (10) N/A\n Self-isolation 41.2 (61) N/A\n Other 14.9 (22) N/A\nSymptomsb\n Rhinitis 16.9 (25) 8.9 (11)\n Coughing 14.2 (21) 6.5 (8)\n Sore throat 4.1 (6) 2.4 (3)\n Dyspnoea 10.8 (16) 2.4 (3)\n Fever 0 (0) 0 (0)\n No symptoms 69.6 (103) 84.6 (104)\nSARS-CoV2 testing\n Tested, positive 0.7 (1) 0.0\n Tested, negative 0.7 (1) 0.0\n Not tested 98.0 (145) 100 (123)\n Unknown 0.7 (1) 0\nHospital admissionc 0.7 (1) 0.0 (0)\n Intensive Care Unit admission 0.0 (0) 0.0 (0)\nLives with adult housemate 85.9 (128) –\nN = 131 N = 106\n% (n) % (n)\nVaccines\n Annual influenza vaccination\n Yes 58.0 (76) 35.8 (38)\n No 42.0 (55) 64.1 (68)\n If available, would take corona vaccine\n Yes 76.3 (100) 68.9 (73)\n No 3.8 (5) 0.9 (1)\n Do not know 19.8 (26) 30.2 (32)\naAffected areas with high risk of COVID-19 as established by National Institute for Public Health and the Environment: Italy, Austria, Nordrhein Westfalen (Germany), Madrid (Spain), China, South Korea, Iran.\nbMultiple answers possible.\ncHospital/ICU admission because of the following symptoms: coughing, dyspnoea and/or fever."}

LitCovid-sentences

LitCovid-PD-HP

{"project":"LitCovid-PD-HP","denotations":[{"id":"T10","span":{"begin":562,"end":570},"obj":"Phenotype"},{"id":"T11","span":{"begin":592,"end":600},"obj":"Phenotype"},{"id":"T12","span":{"begin":621,"end":632},"obj":"Phenotype"},{"id":"T13","span":{"begin":651,"end":659},"obj":"Phenotype"},{"id":"T14","span":{"begin":680,"end":685},"obj":"Phenotype"},{"id":"T15","span":{"begin":1531,"end":1539},"obj":"Phenotype"},{"id":"T16","span":{"begin":1541,"end":1549},"obj":"Phenotype"},{"id":"T17","span":{"begin":1557,"end":1562},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0012384"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0033050"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0002094"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A15","pred":"hp_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A16","pred":"hp_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/HP_0002094"},{"id":"A17","pred":"hp_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/HP_0001945"}],"text":"Table 2 Information on preventive measures, symptoms and hospital admissions related to COVID-19 in CML patients at inclusion.\nPatients (N = 148) Housemates (N = 124)\n% (n) % (n)\nVisited affected areaa 3.4 (5) 4.1 (5)\nPreventive measuresb\n None 0 N/A\n Avoid shaking hands 85.1 (126) N/A\n Clean hands often 84.5 (125) N/A\n Use of face mask 2.7 (4) N/A\n Working from home, just as same-function colleagues 31.8 (47) N/A\n Working from home, in contrary to same-function colleagues 6.8 (10) N/A\n Self-isolation 41.2 (61) N/A\n Other 14.9 (22) N/A\nSymptomsb\n Rhinitis 16.9 (25) 8.9 (11)\n Coughing 14.2 (21) 6.5 (8)\n Sore throat 4.1 (6) 2.4 (3)\n Dyspnoea 10.8 (16) 2.4 (3)\n Fever 0 (0) 0 (0)\n No symptoms 69.6 (103) 84.6 (104)\nSARS-CoV2 testing\n Tested, positive 0.7 (1) 0.0\n Tested, negative 0.7 (1) 0.0\n Not tested 98.0 (145) 100 (123)\n Unknown 0.7 (1) 0\nHospital admissionc 0.7 (1) 0.0 (0)\n Intensive Care Unit admission 0.0 (0) 0.0 (0)\nLives with adult housemate 85.9 (128) –\nN = 131 N = 106\n% (n) % (n)\nVaccines\n Annual influenza vaccination\n Yes 58.0 (76) 35.8 (38)\n No 42.0 (55) 64.1 (68)\n If available, would take corona vaccine\n Yes 76.3 (100) 68.9 (73)\n No 3.8 (5) 0.9 (1)\n Do not know 19.8 (26) 30.2 (32)\naAffected areas with high risk of COVID-19 as established by National Institute for Public Health and the Environment: Italy, Austria, Nordrhein Westfalen (Germany), Madrid (Spain), China, South Korea, Iran.\nbMultiple answers possible.\ncHospital/ICU admission because of the following symptoms: coughing, dyspnoea and/or fever."}

LitCovid-PubTator

{"project":"LitCovid-PubTator","denotations":[{"id":"99","span":{"begin":104,"end":112},"obj":"Species"},{"id":"100","span":{"begin":88,"end":96},"obj":"Disease"},{"id":"101","span":{"begin":100,"end":103},"obj":"Disease"},{"id":"103","span":{"begin":1270,"end":1278},"obj":"Disease"},{"id":"107","span":{"begin":1531,"end":1539},"obj":"Disease"},{"id":"108","span":{"begin":1541,"end":1549},"obj":"Disease"},{"id":"109","span":{"begin":1557,"end":1562},"obj":"Disease"}],"attributes":[{"id":"A99","pred":"tao:has_database_id","subj":"99","obj":"Tax:9606"},{"id":"A100","pred":"tao:has_database_id","subj":"100","obj":"MESH:C000657245"},{"id":"A101","pred":"tao:has_database_id","subj":"101","obj":"MESH:D015464"},{"id":"A103","pred":"tao:has_database_id","subj":"103","obj":"MESH:C000657245"},{"id":"A107","pred":"tao:has_database_id","subj":"107","obj":"MESH:D003371"},{"id":"A108","pred":"tao:has_database_id","subj":"108","obj":"MESH:D004417"},{"id":"A109","pred":"tao:has_database_id","subj":"109","obj":"MESH:D005334"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Table 2 Information on preventive measures, symptoms and hospital admissions related to COVID-19 in CML patients at inclusion.\nPatients (N = 148) Housemates (N = 124)\n% (n) % (n)\nVisited affected areaa 3.4 (5) 4.1 (5)\nPreventive measuresb\n None 0 N/A\n Avoid shaking hands 85.1 (126) N/A\n Clean hands often 84.5 (125) N/A\n Use of face mask 2.7 (4) N/A\n Working from home, just as same-function colleagues 31.8 (47) N/A\n Working from home, in contrary to same-function colleagues 6.8 (10) N/A\n Self-isolation 41.2 (61) N/A\n Other 14.9 (22) N/A\nSymptomsb\n Rhinitis 16.9 (25) 8.9 (11)\n Coughing 14.2 (21) 6.5 (8)\n Sore throat 4.1 (6) 2.4 (3)\n Dyspnoea 10.8 (16) 2.4 (3)\n Fever 0 (0) 0 (0)\n No symptoms 69.6 (103) 84.6 (104)\nSARS-CoV2 testing\n Tested, positive 0.7 (1) 0.0\n Tested, negative 0.7 (1) 0.0\n Not tested 98.0 (145) 100 (123)\n Unknown 0.7 (1) 0\nHospital admissionc 0.7 (1) 0.0 (0)\n Intensive Care Unit admission 0.0 (0) 0.0 (0)\nLives with adult housemate 85.9 (128) –\nN = 131 N = 106\n% (n) % (n)\nVaccines\n Annual influenza vaccination\n Yes 58.0 (76) 35.8 (38)\n No 42.0 (55) 64.1 (68)\n If available, would take corona vaccine\n Yes 76.3 (100) 68.9 (73)\n No 3.8 (5) 0.9 (1)\n Do not know 19.8 (26) 30.2 (32)\naAffected areas with high risk of COVID-19 as established by National Institute for Public Health and the Environment: Italy, Austria, Nordrhein Westfalen (Germany), Madrid (Spain), China, South Korea, Iran.\nbMultiple answers possible.\ncHospital/ICU admission because of the following symptoms: coughing, dyspnoea and/or fever."}

PMC:7341464 / 4130-5693 JSONTXT

Annnotations TAB JSON ListView MergeView

PMC:7341464 / 4130-5693 JSON TXT